The plant () has been used in traditional medicine for years. Many powerful phytochemicals have been isolated from it, making it valuable for modern medicine. It is cheap and native to India.
Research on Solanum nigrum L. shows it has potential anti-tumor effects due to its various bioactive components. Consider using SNL in clinical applications for its therapeutic benefits.
Researchers found that ginger extract had strong anticancer effects on colorectal cancer cells, with high levels of quercetin. This suggests potential for novel and more effective CRC treatments using ginger supplements.
Plumbagin from Plumbago zeylanica inhibits tumor growth by targeting copper-dependent apoptosis in pancreatic cancer cells. Plumbagin prevents copper efflux, induces ROS production, and suppresses specific genes, suggesting its potential as a cancer treatment.
Researchers found that combining curcumin and near-infrared radiation in photodynamic therapy effectively reduces cell proliferation in glioblastoma cells, without harming healthy cells. This promising approach may lead to improved treatment outcomes for this aggressive brain cancer.
Researchers identified potential inhibitors from Dehydrocostus lactone and Mokkolactone for EGFR L858R mutant lung cancer. These compounds showed anti-proliferative activity and stable binding in molecular simulations. Further in vivo studies are needed for efficacy assessment.
Ethanol extract (RCE) inhibits pancreatic cancer cell growth by inducing cell cycle arrest, autophagy, and apoptosis via AKT/mTOR pathway inhibition. Promising potential for anti-cancer treatment.
Innovative phyto-nanomedicine with sea buckthorn polyphenols and metformin inhibits triple-negative breast cancer cells and induces regulated cell death. Promising potential for effective and less genotoxic TNBC therapy.